15 extractive question-and-answer pairs built from 1725952332 psychiatry depression, published by icmr.gov.in. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 11 of the 15 pairs (73.3%) are explanatory questions and 4 restate a figure. 100.00% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/psychiatry-and-depression-question-and-answer-dataset/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("psychiatry-and-depression-question-and-answer-dataset")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Consensus Document on Management of Pancreatic Cancer - Question and Answer Dataset
Economy · 268 rows
ICMR Standard Treatment Workflow for Cataract - Question and Answer Dataset
Economy · 27 rows
Neurology Questions from P a R T N E R S - Question and Answer Dataset
Economy · 107 rows
Beginner's Guide for Systematic Reviews - Question and Answer Dataset
Economy · 407 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 10 of 15 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What is the expected timeline for improvement when using SSRIs for depression? | Improvement starts in in 2nd week and expect adequate response by 6 weeks | • Difficulty in making diagnosis • No improvement after 4 to 6 weeks of treatment with first line medications • Depression in special population: Elderly / Pregnancy / Lactation / Children / Adolescents • Comorbid medical illness / Substance use • Suicidal risk assessment • Selective Serotonin Reuptake Inhibiters (SSRI) are usually first choice (watch for GI bleed and drug interaction) • Improvement starts in in 2nd week and expect adequate response by 6 weeks • Duration of treatment typically lasts 6-9 months and Gradual tapering of medication advised for first episode • Restart SSRI , In case of resurgence and recurrence of depressive symptoms • Observe for switch / activation with Antidepressants • Watch for risk of overdose with TCA (Amitriptyline / Imipramine) and Mirtazapine • Confirm Diagnosis and Suicide risk assessment • Assess for other Medical Comorbidities • Investigations – Haemoglobin,Thyroid Function Test, Electrocardiogram • Non Responder - Switch over to SNRI (Venlafaxine 75 – 150 mg, Mirtazapine | 391 | summary | 0.970 | • Difficulty in making diagnosis • No improvement after 4 to 6 weeks of treatment with first line medications • Depression in special population: Elderly / Pregnancy / Lactation / Children / Adolescents • Comorbid medical illness / Substance use • Suicidal risk assessment • Selective Serotonin Reuptake Inhibiters (SSRI) are usually first choice (watch for GI bleed and drug interaction) • Improvement starts in in 2nd week and expect adequate response by 6 weeks • Duration of treatment typically lasts 6-9 months and Gradual tapering of medication advised for first episode • Restart SSRI , In | 1 | page=1,block=13 | 0.700 | valid |
| What are some cognitive issues linked to depression? | • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) | • Reduced concentration and attention • Reduced self-esteem and self-confidence • Ideas of guilt and unworthiness • Bleak and pessimistic views of the future • Ideas or acts of self-harm or suicide • Disturbed sleep • Diminished appetite To make a diagnosis of depression, symptoms must present for at least 2 weeks. Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 327 | list | 0.820 | Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 1 | page=1,block=7 | 0.700 | valid |
| What are some common physical symptoms of depression? | • Disturbed sleep • Diminished appetite | • Reduced concentration and attention • Reduced self-esteem and self-confidence • Ideas of guilt and unworthiness • Bleak and pessimistic views of the future • Ideas or acts of self-harm or suicide • Disturbed sleep • Diminished appetite To make a diagnosis of depression, symptoms must present for at least 2 weeks. Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 198 | list | 0.820 | • Reduced concentration and attention • Reduced self-esteem and self-confidence • Ideas of guilt and unworthiness • Bleak and pessimistic views of the future • Ideas or acts of self-harm or suicide • Disturbed sleep • Diminished appetite To make a diagnosis of depression, symptoms must present for at least 2 weeks. | 1 | page=1,block=7 | 0.700 | valid |
| What aspects are evaluated when assessing suicide risk? | • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | • Reduced concentration and attention • Reduced self-esteem and self-confidence • Ideas of guilt and unworthiness • Bleak and pessimistic views of the future • Ideas or acts of self-harm or suicide • Disturbed sleep • Diminished appetite To make a diagnosis of depression, symptoms must present for at least 2 weeks. Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 443 | list | 0.820 | Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 1 | page=1,block=7 | 0.700 | valid |
| What potential complications should be monitored when using SSRIs? | GI bleed and drug interaction | • Difficulty in making diagnosis • No improvement after 4 to 6 weeks of treatment with first line medications • Depression in special population: Elderly / Pregnancy / Lactation / Children / Adolescents • Comorbid medical illness / Substance use • Suicidal risk assessment • Selective Serotonin Reuptake Inhibiters (SSRI) are usually first choice (watch for GI bleed and drug interaction) • Improvement starts in in 2nd week and expect adequate response by 6 weeks • Duration of treatment typically lasts 6-9 months and Gradual tapering of medication advised for first episode • Restart SSRI , In case of resurgence and recurrence of depressive symptoms • Observe for switch / activation with Antidepressants • Watch for risk of overdose with TCA (Amitriptyline / Imipramine) and Mirtazapine • Confirm Diagnosis and Suicide risk assessment • Assess for other Medical Comorbidities • Investigations – Haemoglobin,Thyroid Function Test, Electrocardiogram • Non Responder - Switch over to SNRI (Venlafaxine 75 – 150 mg, Mirtazapine | 358 | list | 0.820 | • Difficulty in making diagnosis • No improvement after 4 to 6 weeks of treatment with first line medications • Depression in special population: Elderly / Pregnancy / Lactation / Children / Adolescents • Comorbid medical illness / Substance use • Suicidal risk assessment • Selective Serotonin Reuptake Inhibiters (SSRI) are usually first choice (watch for GI bleed and drug interaction) • Improvement starts in in 2nd week and expect adequate response by 6 weeks • Duration of treatment typically lasts 6-9 months and Gradual tapering of medication advised for first episode • Restart SSRI , In | ||||
| What therapies are suggested as non-pharmacological options for treating depression? | • Cognitive Behavioral Therapy / Problem Solving Therapy • Add on Yoga Therapy / Meditation | 225mg / Imipramine 75 -225mg) • Cognitive Behavioral Therapy / Problem Solving Therapy • Add on Yoga Therapy / Meditation • Gautam S et al. Clinical Practice Guidelines for the management of Depression. Indian J Psychiatry. 2017;59(Suppl 1):S34-S50. • Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry 2018;60, Suppl S3:341-62 • Sarkar S, Grover S. A systematic review and meta-analysis of trials of antidepressants in India for treatment of depression. Indian J Psychiatry. 2014;56:29–38 • National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care. Clinical Guideline 23. London: NICE, 2004. • mhGAP Intervention Guide - Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings. World Health Organisation, 2016 | 30 | list | 0.820 | 225mg / Imipramine 75 -225mg) • Cognitive Behavioral Therapy / Problem Solving Therapy • Add on Yoga Therapy / Meditation • Gautam S et al. | 1 | page=1,block=46 | 0.700 | |
| What are some cognitive symptoms associated with depression? | • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) | • Reduced concentration and attention • Reduced self-esteem and self-confidence • Ideas of guilt and unworthiness • Bleak and pessimistic views of the future • Ideas or acts of self-harm or suicide • Disturbed sleep • Diminished appetite To make a diagnosis of depression, symptoms must present for at least 2 weeks. Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 327 | list | 0.820 | Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 1 | page=1,block=7 | 0.700 | valid |
| What factors are assessed to evaluate suicide risk? | • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | • Reduced concentration and attention • Reduced self-esteem and self-confidence • Ideas of guilt and unworthiness • Bleak and pessimistic views of the future • Ideas or acts of self-harm or suicide • Disturbed sleep • Diminished appetite To make a diagnosis of depression, symptoms must present for at least 2 weeks. Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 443 | list | 0.820 | Cognition • Hopelessness (about future) • Helplessness (about others) • Worthlessness (about self) Assessment of Suicide Risk • Suicidal thoughts • Suicidal idea • Suicidal intent • Immediate risk for attempt | 1 | page=1,block=7 | 0.700 | valid |
| What are some risks associated with using SSRIs for depression treatment? | GI bleed and drug interaction | • Difficulty in making diagnosis • No improvement after 4 to 6 weeks of treatment with first line medications • Depression in special population: Elderly / Pregnancy / Lactation / Children / Adolescents • Comorbid medical illness / Substance use • Suicidal risk assessment • Selective Serotonin Reuptake Inhibiters (SSRI) are usually first choice (watch for GI bleed and drug interaction) • Improvement starts in in 2nd week and expect adequate response by 6 weeks • Duration of treatment typically lasts 6-9 months and Gradual tapering of medication advised for first episode • Restart SSRI , In case of resurgence and recurrence of depressive symptoms • Observe for switch / activation with Antidepressants • Watch for risk of overdose with TCA (Amitriptyline / Imipramine) and Mirtazapine • Confirm Diagnosis and Suicide risk assessment • Assess for other Medical Comorbidities • Investigations – Haemoglobin,Thyroid Function Test, Electrocardiogram • Non Responder - Switch over to SNRI (Venlafaxine 75 – 150 mg, Mirtazapine | 358 | list | 0.820 | • Difficulty in making diagnosis • No improvement after 4 to 6 weeks of treatment with first line medications • Depression in special population: Elderly / Pregnancy / Lactation / Children / Adolescents • Comorbid medical illness / Substance use • Suicidal risk assessment • Selective Serotonin Reuptake Inhibiters (SSRI) are usually first choice (watch for GI bleed and drug interaction) • Improvement starts in in 2nd week and expect adequate response by 6 weeks • Duration of treatment typically lasts 6-9 months and Gradual tapering of medication advised for first episode • Restart SSRI , In | ||||
| What are some non-pharmacological therapies recommended for depression management? | • Cognitive Behavioral Therapy / Problem Solving Therapy • Add on Yoga Therapy / Meditation | 225mg / Imipramine 75 -225mg) • Cognitive Behavioral Therapy / Problem Solving Therapy • Add on Yoga Therapy / Meditation • Gautam S et al. Clinical Practice Guidelines for the management of Depression. Indian J Psychiatry. 2017;59(Suppl 1):S34-S50. • Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry 2018;60, Suppl S3:341-62 • Sarkar S, Grover S. A systematic review and meta-analysis of trials of antidepressants in India for treatment of depression. Indian J Psychiatry. 2014;56:29–38 • National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care. Clinical Guideline 23. London: NICE, 2004. • mhGAP Intervention Guide - Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings. World Health Organisation, 2016 | 30 | list | 0.820 | 225mg / Imipramine 75 -225mg) • Cognitive Behavioral Therapy / Problem Solving Therapy • Add on Yoga Therapy / Meditation • Gautam S et al. | 1 | page=1,block=46 | 0.700 |
Read straight from the file — download or use the API URL for the full dataset.
| 1 |
| page=1,block=13 |
| 0.700 |
| valid |
| valid |
| 1 |
| page=1,block=13 |
| 0.700 |
| valid |
| valid |